SOPHARMA (SPH) komunikat - Current report 8 buy back 21012016

POLISH FINANCIAL SUPERVISION AUTHORITY
		UNI - EN REPORT No		8	/	2016
Date of issue:	2016-01-21
Short name of the issuer
SOPHARMA AD
Subject
Current report 8 buy back 21012016
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
SOPHARMA AD hereby informs that from 14 January 2016 up to and including 20 January 2016 the Company bought 2000 own shares representing 0.0015% of the share capital of the Company, at a total value of 5 312.00 BGN on the Bulgarian Stock Exchange, the average price per share was 2.66 BGN.The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 221 296, representing 3.87% of the share capital of the Company.
Annexes
File			Description
			Current report 8 buy back 21012016

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date	Name	Position / Function	Signature
2016-01-21	Ognian Donev	Executive director

Konta:	Konta osobiste Konta młodzieżowe Konta firmowe Konta walutowe
Kredyty:	Kredyty gotówkowe Kredyty mieszkaniowe Kredyty z dopłatą Kredyty dla firm

Current report 8 buy back 21012016